secwatch.observer — SEC 8-K summary
======================================

Issuer:     Avalon GloboCare Corp. (ALBT)
CIK:        0001630212
Form:       8-K
Filed at:   2025-04-10T23:59:59+00:00
Accession:  0001213900-25-030435
Event type: other_material
Sentiment:  positive
Materiality: 0.55
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Avalon GloboCare granted Chinese patent for CAR-T/NK cell technology; term 20 years
--------------------------------------------------------------------------------

- Patent CN 114502188 B issued by CNIPA, effective April 4, 2025, with 20-year protection.
- Co-developed with Hong Kong-based Arbele Limited; covers bispecific anti-CD19xCD22 CAR and localized cytokine induction.
- Enhances expansion, manufacturing, survival, and efficacy of CAR-T and CAR-NK cells.
- Adds to existing U.S. and PCT protections, strengthening global IP portfolio for cell-based immunotherapy.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1630212/000121390025030435/0001213900-25-030435-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1630212/000121390025030435/ea0237706-8k_avalon.htm
  HTML page:      https://secwatch.observer/filing/0001213900-25-030435

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer